Previous 10 | Next 10 |
Channelchek news releases related Channelchek news releases and Channelchek press releases from 06/07/22 12:00:00 on US and Canada Markets.
Gevo announces offering. The company has entered into an agreement with several institutional investors to sell 33,333,336 shares of common stock at a $4.50 per share, the approximate previous closing price, with accompanying warrants exercisable at $4.37 per share. The offering will generate ...
Phase I exploration at Dale. Element79 recently provided an update on the results of its 2021 Phase I exploration program at the Dale property, located within the Swayze Greenstone Belt in Ontario, Canada. The work program, designed to follow up on several prospecting samples that yielded up t...
1Q22 Results. GABY reported first quarter revenue of $7.3 million (all figures in CAD$), up from $3.4 million reported last year, driven by the acquisition of Mankind, but down from the $8.2 million in 4Q21. We had estimated revenue of $8.5 million. Variable gross margin for the quarter improv...
New Distributor. Avivagen's management recently announced the Company has signed a new distribution agreement with Nong San Viet Co. to support the continued expansion of Avivagen's OxC-beta feed additive. No details were given on the length of the agreement. We believe that this new distribut...
CARLSBAD, Calif.--(BUSINESS WIRE)--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that it has expanded its existing collaboration with Advanced BioMatrix, a div...
MIAMI, June 02, 2022 (GLOBE NEWSWIRE) -- Motorsport Games Inc. (NASDAQ: MSGM) (“Motorsport Games” or the “Company”), a leading racing game developer, publisher and esports ecosystem provider of official motorsport racing series throughout the world, announces today ...
FLORHAM PARK, N.J., June 02, 2022 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a growing pipeline of molecularly targeted cancer immunotherapies and infectious disease vaccines based on the Company’s proprietary Vers...
VIRGINIA CITY, NEVADA, JUNE 2, 2022 – Comstock Inc. (NYSE: LODE) (“Comstock” and the “Company”) announced today that it had conducted its Annual Meeting of Shareholders on May 26, 2022, providing shareholders updates on the Company’s commercialization ...
TROY, Mich., June 2, 2022 /PRNewswire/ -- Kelly (Nasdaq: KELYA, KELYB), a leading specialty talent solutions provider, today announced it will participate in the Sidoti Virtual Investor Conference on Thursday, June 16, 2022. Read More >>
REHOVOT, Israel and WILMINGTON, Del., June 02, 2022 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (Nasdaq: AYLA), a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers, primarily in gene...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
14.86%Change Percent:
Webster Financial Corporation Company Name:
WBS Stock Symbol:
NYSE Market:
websterbank.com Website: